Trial Profile
Phase 3 study of MDNA55 in patients with IL4R positive cancers
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Bizaxofusp (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 28 Dec 2015 New trial record